Cruyssen, B. V., Van Looy, S., Wyns, B., Westhovens, R., Durez, P., Van den Bosch, F., . . . De Keyser, F. (2006). Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: Attrition and long-term evolution of disease activity. BioMed Central.
Chicago-tyylinen lähdeviittausCruyssen, Bert Vander, et al. Four-year Follow-up of Infliximab Therapy in Rheumatoid Arthritis Patients With Long-standing Refractory Disease: Attrition and Long-term Evolution of Disease Activity. BioMed Central, 2006.
MLA-viiteCruyssen, Bert Vander, et al. Four-year Follow-up of Infliximab Therapy in Rheumatoid Arthritis Patients With Long-standing Refractory Disease: Attrition and Long-term Evolution of Disease Activity. BioMed Central, 2006.